I suspect there wouldn't have been recent cap raise if commercial deal was imminent. Still hopeful ALT can sell for $30-$40m in next 6 months (maybe get 1.2-1.5c p/shre?)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024